FDA approves over-the-counter Narcan. Here's what it means

FDA approves over-the-counter Narcan

Here’s a look at the issues involvedGeoff MulvihillAssociated PressThe U.S. Food and Drug Administration on Wednesday approved selling the leading version of naloxone without a prescription, setting the overdose-reversing drug on course to become the first opioid treatment drug to be sold over the counter.It’s a move that some advocates have long sought as a way to improve access to a life-saving drug, though the exact impact will not be clear i…

FDA approves over-the-counter Narcan. Here's what it means

The U.S. Food and Drug Administration on Wednesday approved selling the leading version of naloxone without a prescription, setting the overdose-reversing drug on course to become the first opioid treatment drug to be sold over the counter.It's a move that some advocates have long sought as a way to improve access to a life-saving drug, though the exact impact will not be clear immediately.Here's a look at the issues involved.WHAT IS NARCAN?The …

FDA approves Narcan for over-the-counter sales

Wednesday the U.S. Food and Drug Administration approved Narcan, the opioid overdose-reversing drug, for over-the-counter, non-prescription sale.

FDA Approves Narcan for Over-the-Counter Use

A life-saving medication that rapidly reverses the effects of opioid overdoses will soon become way easier to get. The federal Food and Drug Administration has approved naloxone, or Narcan Nasal Spray, for over-the-counter use. Naloxone has been available at most Missouri pharmacies without prescriptions since 2017.

FDA approves over-the-counter Narcan. Here's what it means

It’s a move that some advocates have long sought as a way to improve access to a life-saving drug, though the exact impact will not be clear immediately.

FDA approves over-the-counter Narcan. Here's what it means

It’s a move that some advocates have long sought as a way to improve access to a life-saving drug, though the exact impact will not be clear immediately.